Eritrea vs Switzerland: Prevalence rate of hypertension in adults aged 30-79
Eritrea
23.7
in 2019
Switzerland
21.9
in 2019
Eritrea rank
191st
Switzerland rank
193rd
Prevalence rate of hypertension in adults aged 30-79 over time
- Eritrea
- Switzerland
How they compare
Eritrea currently reports 23.7 against 21.9 in Switzerland, a difference of 1.8.
That makes Eritrea's figure about 1.1 times Switzerland's.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Switzerland ahead.
Eritrea ranks 191st and Switzerland ranks 193rd of 194 countries.
Across the 3 decades both report, Eritrea averaged higher in 1 and Switzerland in 2.
Head to head by decade
| Decade | Eritrea | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 25.4 | 32.69 | 7.29 | Switzerland |
| 2000s | 25.05 | 29.3 | 4.25 | Switzerland |
| 2010s | 24.34 | 24.31 | 0.03 | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Eritrea or Switzerland?
- Eritrea, at 23.7 against 21.9 in Switzerland as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Eritrea and Switzerland?
- 1.8, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Switzerland?
- 30 years are reported by both, from 1990 to 2019.
- How do Eritrea and Switzerland rank globally for prevalence rate of hypertension in adults aged 30-79?
- Eritrea ranks 191st and Switzerland ranks 193rd of 194 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.